Richland Equities logo

Richland Equities

Asia, Guangdong, China, Shenzhen

Description

Richland Equities is a Chinese private equity investment company focused on areas such as TMT, advanced manufacturing, healthcare, and more.

Investor Profile

Richland Equities has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (33%)
  • Series D (33%)
  • Series C (33%)

Country Focus

  • China (100%)

Industry Focus

  • 3d Technology
  • Generative Ai
  • Information Technology
  • Industrial Manufacturing
  • Manufacturing
  • Semiconductor
  • Biopharma
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Richland Equities frequently co-invest with?

Meitu
Asia, Fujian, China, Xiamen
Co-Investments: 1
Yida China Holdings
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Haitong Innovation Capital Management
Asia, Shanghai, China, Jingan
Co-Investments: 1
China Merchants Fund
Asia, Guangdong, China, Futian
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
CD
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Titanium Capital
North America, Florida, United States, North Palm Beach
Co-Investments: 1

What are some of recent deals done by Richland Equities?

Seele

Shenzhen, Guangdong, China

Seele is crafting 3D Multi-Modal Large Models and social gaming platform for everyone to generate 3D interactions efficiently.

3D TechnologyGenerative AIInformation Technology
SeedNov 17, 2024
Amount Raised: $10,000,000
Innoscience

Zhuhai, Guangdong, China

Innoscience is an 8-inch Integrated Device Manufacture (IDM) that focuses on GaN technology.

Industrial ManufacturingManufacturingSemiconductor
Series DFeb 16, 2022
Amount Raised: $410,282,306
Transcenta

Huangpu, Shanghai, China

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

BiopharmaBiotechnology
Series CDec 23, 2020
Amount Raised: $105,000,000